Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (1), 382

Novel Therapies for Treating Familial Hypercholesterolemia


Novel Therapies for Treating Familial Hypercholesterolemia

Salman J Bandeali et al. Curr Atheroscler Rep.


Familial hypercholesterolemia is an inherited disorder associated with early accelerated atherosclerosis with morbidity and mortality resulting from premature cardiovascular disease. Affected individuals have extreme elevations in low-density lipoprotein cholesterol levels. Patients usually do not achieve target reductions in cholesterol levels with conventional antihyperlipidemic pharmacotherapy. This unmet need has resulted in the recent development and approval of novel therapies targeting different cholesterol pathways. This article briefly summarizes familial hypercholesterolemia and then discusses the newer pharmacotherapies available in the management of familial hypercholesterolemia.

Similar articles

See all similar articles

Cited by 1 article


    1. Atherosclerosis. 2010 Feb;208(2):317-21 - PubMed
    1. J Clin Invest. 2003 Jun;111(12):1795-803 - PubMed
    1. J Clin Lipidol. 2010 Sep-Oct;4(5):350-6 - PubMed
    1. JAMA Intern Med. 2013 Sep 9;173(16):1491-2 - PubMed
    1. Proc Natl Acad Sci U S A. 2004 May 4;101(18):7100-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources